Aerovate Therapeutics Ownership | Who Owns Aerovate Therapeutics?


OverviewForecastFinancialsChart

Aerovate Therapeutics Ownership Summary


Aerovate Therapeutics is owned by 1.71% institutional investors, 0.02% insiders, and 98.28% retail investors. Blackrock is the largest institutional shareholder, holding 3.54% of AVTE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.85% of its assets in Aerovate Therapeutics shares.

AVTE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAerovate Therapeutics1.71%0.02%98.28%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock983.06K3.54%$1.63M
Artal group809.60K2.91%$1.34M
Goldman sachs group314.37K1.09%$833.08K
Alliancebernstein69.91K0.24%$185.26K
Susquehanna group, llp57.75K0.20%$153.04K
Bnp paribas arbitrage, snc54.69K0.19%$144.92K
Morgan stanley51.77K0.19%$85.94K
Fifth lane capital, lp50.00K0.18%$83.00K
Nuveen asset management40.05K0.14%$106.12K
Cubist systematic strategies31.89K0.11%$52.94K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fifth lane capital, lp50.00K0.12%$83.00K
Artal group809.60K0.03%$1.34M
Gg group ventures13.09K0.03%$22.91K
Quarry lp22.50K0.01%$37.35K
Cubist systematic strategies31.89K0.00%$52.94K
Lmr partners llp14.10K0.00%$23.41K
Tower research capital llc (trc)3.87K0.00%$10.24K
Alliancebernstein69.91K0.00%$185.26K
Bnp paribas arbitrage, snc54.69K0.00%$144.92K
Goldman sachs group314.37K0.00%$833.08K

Top Buyers

HolderShares% AssetsChange
Artal group809.60K0.03%809.60K
Blackrock983.06K-273.31K
Goldman sachs group314.37K0.00%153.36K
Susquehanna group, llp57.75K-57.75K
Bnp paribas arbitrage, snc54.69K0.00%54.69K

Top Sellers

HolderShares% AssetsChange
Ra capital management---9.19M
Sofinnova investments---3.76M
Tcg crossover management---2.24M
Atlas venture life science advisors---1.80M
Adar1 capital management---1.46M

New Positions

HolderShares% AssetsChangeValue
Artal group809.60K0.03%809.60K$1.34M
Bnp paribas arbitrage, snc54.69K0.00%54.69K$144.92K
Fifth lane capital, lp50.00K0.12%50.00K$83.00K
Cubist systematic strategies31.89K0.00%31.89K$52.94K
Quarry lp22.50K0.01%22.50K$37.35K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
True wealth design-9.00
Advisor group-12.00
Sterling capital management-13.00
Eversource wealth advisors-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20258-90.36%17,315,633-42.60%10.02%3-94.12%1-92.31%
Dec 31, 2024826.49%30,155,8309.09%1041.14%5028.21%13-18.75%
Sep 30, 202477-17.20%27,644,2911.70%951.00%39-37.10%1614.29%
Jun 30, 20249317.72%27,181,983-4.43%970.93%6255.00%14-39.13%
Mar 31, 20247925.40%28,443,1270.96%1020.89%4029.03%2335.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv536.62K1.85%52.67K
iShares Russell 2000 ETF458.98K1.58%-3.96K
Vanguard VIF Small Co Gr213.89K0.74%-76.53K
Vanguard Institutional Extnd Mkt Idx Tr202.52K0.70%-
State St Russell Sm/Mid Cp® Indx SL Cl I172.19K0.59%-
State St Russell Sm/Mid Cp® Indx NL Cl C172.19K0.59%-
Bridge Builder Tax Managed Sm/Md Cp124.13K0.43%-
iShares Russell 2000 Growth ETF110.99K0.38%-528.00
Vanguard Russell 2000 ETF62.88K0.22%1.38K
Fidelity Enhanced Small Cap ETF48.26K0.17%-336.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 17, 2024RA CAPITAL MANAGEMENT, L.P. Buy$1.55M
Jun 14, 2024Eldridge George A SEE REMARKSSell$375.45K
Jun 14, 2024Verwijs Marinus CHIEF TECHNICAL OFFICERSell$265.00K
Jun 13, 2024Gillies Hunter CHIEF MEDICAL OFFICERSell$147.00K
May 17, 2024Gillies Hunter CHIEF MEDICAL OFFICERSell$82.45K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2129
2024 Q1-23
2023 Q4-12
2023 Q3-10

AVTE Ownership FAQ


Who Owns Aerovate Therapeutics?

Aerovate Therapeutics shareholders are primarily institutional investors at 1.71%, followed by 0.02% insiders and 98.27% retail investors. The average institutional ownership in Aerovate Therapeutics's industry, Biotech Stocks , is 64.05%, which Aerovate Therapeutics falls below.

Who owns the most shares of Aerovate Therapeutics?

Aerovate Therapeutics’s largest shareholders are Blackrock (983.06K shares, 3.54%), Artal group (809.6K shares, 2.91%), and Goldman sachs group (314.37K shares, 1.09%). Together, they hold 7.54% of Aerovate Therapeutics’s total shares outstanding.

Does Blackrock own Aerovate Therapeutics?

Yes, BlackRock owns 3.54% of Aerovate Therapeutics, totaling 983.06K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.63M$. In the last quarter, BlackRock increased its holdings by 273.31K shares, a 38.51% change.

Who is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested?

Fifth lane capital, lp is Aerovate Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.12% of its assets in 50K Aerovate Therapeutics shares, valued at 83K$.

Who is the top mutual fund holder of Aerovate Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aerovate Therapeutics shares, with 1.85% of its total shares outstanding invested in 536.62K Aerovate Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools